New Anti-Obesity Meds and ECT: LTE in JECT
Out on PubMed, in JECT, is this LTE:
Reply to "Glucagon-Like Peptide-1 Receptor Agonists During Electroconvulsive Therapy: Case Report With Evolving Concerns and Management Considerations".J ECT. 2024 Jul 10. doi: 10.1097/YCT.0000000000001053. Online ahead of print.
PMID: 38984842
The LTE is here:
Here is an LTE about management strategies for ECT patients on the new GLP-1 receptor agonists. The issue is delayed gastric emptying and the risk of aspiration.
I think we are still in a period in which we are learning how much of an actual clinical risk this really is.
Please see also:
Glucagon-Like Peptide-1 Receptor Agonists During Electroconvulsive Therapy: Case Report With Evolving Concerns and Management Considerations.
J ECT. 2024 Feb 2. doi: 10.1097/YCT.0000000000000992. Online ahead of print.PMID: 38315827
Comments
Post a Comment